SCHEMBL1062964

SCHEMBL1062964

CN1CC[CH]C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825324 0.84
SCHEMBL6201675 0.82
SCHEMBL761830 0.74
SCHEMBL6201529 0.72 BRD4 (0.31)
SCHEMBL6196698 0.69
SCHEMBL9020974 0.67
SCHEMBL11115684 0.67
SCHEMBL4699002 0.67
SCHEMBL8305417 0.65
SCHEMBL5473121 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208970-A1 SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE CARLSSON JENS (SE) 2024-06-27 US claimed
US-12012409-B2 Bicyclic heterocycles as FGFR inhibitors INCYTE CORPORATION (US) 2024-06-18 US claimed
CN-117751105-A Substituted hydantoin compounds, process for their preparation and their use in the treatment and/or prophylaxis of coronavirus diseases J·卡尔松 2024-03-22 CN claimed
EP-4329883-A1 SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE Carlsson, Jens (SE) 2024-03-06 EP claimed
US-20230416205-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2023-12-28 US claimed
US-11834439-B2 Compounds, compositions, and methods DENALI THERAPEUTICS INC. (US) 2023-12-05 US claimed
EP-3436461-B1 PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS INCYTE CORP (US) 2023-11-01 EP claimed
EP-4247376-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Denali Therapeutics Inc. (US) 2023-09-27 EP claimed
CN-116507608-A Compounds, compositions, and methods 戴纳立制药公司 2023-07-28 CN claimed
US-20230227436-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-07-20 US claimed
US-6180621-B1 ADMINISTERING TO WARM-BLOODED ANIMALS FOR TREATMENT AND PREVENTION OF INFECTIOUS DISEASES CAUSED BY HELICOBACTER PYLORI SANKYO COMPANY, LIMITED (JP) 2001-01-30 US claimed
EP-1019047-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 2000-07-19 EP claimed
EP-0980367-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 2000-02-23 EP claimed
CN-1225011-A Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient SANKYO CO (JP) 1999-08-04 CN claimed
EP-0913151-A1 ANTI-HELICOBACTER PYLORI COMPOSITIONS CONTAINING 1-METHYLCARBAPENEM DERIVATIVES AS THE ACTIVE INGREDIENT Sankyo Company, Limited (JP) 1999-05-06 EP claimed
WO-1998049161-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1998-11-05 WO claimed
WO-1998048800-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1998-11-05 WO claimed
US-5270308-A Hypotensives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-12-14 US claimed
CN-1060467-A 1,3-benzoxazine derivatives, its production method and purposes TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1992-04-22 CN claimed
EP-0477789-A1 1,3-Benzoxazine derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1992-04-01 EP claimed